![]() Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. | ||
Founding Date | Founding Date 2003 | Founding Date 2000 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Menlo Park, US HQ | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 4337% increase | Employees 2048% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $76.7m (FY, 2021) | Gross profit $71m (FY, 2024) |
Net income | Net income ($159.6m) (FY, 2021) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | ||
Patents (US) | Patents (US) 30 (FY, 2016) | Patents (US) 43 (Jun, 2017) |
Trademarks (US) | Trademarks (US) 4 (FY, 2016) | Trademarks (US) 3 (Jun, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 102.9m | Total funding raised $ 120.5m |

OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company